Follow
Tejasvini Bhuvan
Tejasvini Bhuvan
Verified email at monash.edu
Title
Cited by
Cited by
Year
Mesenchymal stromal cell apoptosis is required for their therapeutic function
SHM Pang, J D’Rozario, S Mendonca, T Bhuvan, NL Payne, D Zheng, ...
Nature communications 12 (1), 6495, 2021
1322021
Biological considerations in scaling up therapeutic cell manufacturing
DS Cherian, T Bhuvan, L Meagher, TSP Heng
Frontiers in Pharmacology 11, 654, 2020
562020
Secondary lymphoid organs in mesenchymal stromal cell therapy: more than just a filter
D Zheng, T Bhuvan, NL Payne, TSP Heng
Frontiers in Immunology 13, 892443, 2022
62022
Mesenchymal stromal cell apoptosis is required for their therapeutic function. Nat Commun. 2021; 12 (1): 6495
SHM Pang, J D’Rozario, S Mendonca, T Bhuvan, NL Payne, D Zheng
6
Mesenchymal Stem/Stromal Cells: ROUTE-DEPENDENT MECHANISMS OF MESENCHYMAL STROMAL CELL THERAPY
D Zheng, T Bhuvan, N Payne, T Heng
Cytotherapy 25 (6), S60, 2023
2023
The short chain fatty acid butyrate prevents intracellular replication of Legionella by regulating cysteine levels in macrophages
G Abraham, A Swaminathan, C Barlow, T Nguyen, T Bhuvan, T Heng, ...
2021
Immunometabolic changes in resident macrophages underlie msc therapeutic effects
S Pang, T Bhuvan, D Zheng, S Mendonca, J D’Rozario, D Powell, T Heng
Cytotherapy 23 (5), S63-S64, 2021
2021
Is mesenchymal stromal cell apoptosis necessary for their immunomodulatory capacity?
S Pang, J D'Rozario, G Wallis, A Hisana, T Bhuvan, N Payne, D Powell, ...
Cytotherapy 22 (5), S87, 2020
2020
Investigating the role of apoptosis and tissue macrophages in mesenchymal stromal cell treatment of inflammatory lung diseases
T BHUVAN
Monash University, 0
The system can't perform the operation now. Try again later.
Articles 1–9